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Cancer Cytogenetics: Chromosomal and
Molecular Genetic Aberrations of Tumour
Cells, 2nd edn
EditedbyS Heim and FMitelman, Chichester, UK:
Wiley-Liss, 1995, pp 536, £50.00, ISBN 0-471-12052-9.
Since thepublication ofthe firstedition ofthis book in 1987, many
significant developments have taken place in the field of cancer
cytogenetics that have been meticulously addressed in this much
expanded second edition. This new book provides a critical up-to-
date review of chromosome rearrangements in terms of termi-
nology, methodology and background of chromosome changes in
cancer. The text includes a description ofcytogenetic changes and
their known molecular correlates in all types of malignancy. This
includes the major subdivisions ofleukaemia, their related haema-
tological disorders and lymphomas, as in the first edition, and, in
this new edition, the solid tumours. The vast expansion ofknowl-
edge in the areas of solid tumour cytogenetics and the molecular
genetics of neoplastic cells in recent years has resulted in a
doubling in size ofthis second edition.
The subject of this book is the description and understanding of
the neoplastic processes at the chromosomal level of genomic
organization. It provides a wealth oforiginal references and review
papers on topics related to questions concerning the molecular
genetic aspects ofall tumourtypes. Iteffectively combines the liter-
ature on chromosome alterations in malignancy in relation to their
clinical and biological significance. This was necessary as the
importance of chromosome rearrangements in malignancy can
easily be lost within the diversity of the numerous cytogenetic
publications. Thus Cancer Cytogenetics becomes a highly valuable
reference text that places good, updated cytogenetic information in
the form of an excellent review against the background of molec-
ular changes and clinicopathological-correlations for both the
haematopoietic and solid tumours of man. In general, this book
represents an excellent overview ofthe many important advances in
the cytogenetics of malignant disorders. Despite the certainty that
new discoveries will be made, the basic information in this book
will continue to form an excellent reference source to aid in the
interpretation ofnew findings as they become available in the field.
This book is invaluable to pathologists, cancer biologists,
human geneticists and cytogeneticists interested in learning more
about the specificity and significance of chromosome rearrange-
ments in cancer.
Christine Harrison, Paterson Institutefor CancerResearch, Christie
HospitalNHS Trust, WilmslowRoad, ManchesterM209BX, UK
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4-8 September 1997
20th LH Gray Conference: Molecular stress responses,
cancer therapy and radiation injury
York, UK
Further informationfrom:
Dr JV Moore, Paterson Institute for Cancer Research, Christie
Hospital, Manchester M20 4BX, UK. Tel: +44 (0161) 446 3199
E-mail: rdbjvm@picr.cr.man.ac.uk
17September 1997
4th Annual Conference 'Molecular Biology of Colon and
Rectal Cancer'
Minnesota, USA
Further informationfrom:
Continuing Medical Education, University ofMinnesota, 107
Radisson Hotel Metrodome, 615 Washington Avenue S.E.,
Minneapolis, MN 55414, USA. Tel: (612) 626-7600 (Toll free
1-800-776-8636) Fax: (612) 626-7766
E-Mail: http://www.cee.umn.edu:80/cme/
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The British Prostate Group 2nd International
Symposium on Prostate Disease
An inter-disciplinary meeting of clinical and basic scientists
to be held at York University, York, UK.
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Cells and Immunity
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Dr Josip Herdekovic, European Science Foundation,
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Leukemia and Lymphoma
Amsterdam, The Netherlands
Further informationfrom:
VU Conference Service, De Boelelaan 1105, 1081 HV
Amsterdam, The Netherlands, Tel: +31 20 444 5790,
Fax: +31 20 444 5825
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